Avoid placing medication in the refrigerator door where temperature fluctuates, and keep it in the original carton to protect from light
Without naming Anthropic, whose CEO Dario Amodei has repeatedly warned about AI dangers, Altman said, "I also think some of the alternative visions painted by other companies are quite terrifying," according to Business Insider
It's an investigational drug currently in Phase 3 clinical trials Eli Lilly's TRIUMPH Phase 3 program includes multiple trials for obesity, type 2 diabetes, NASH, and cardiovascular outcomes Expected timeline: FDA submission in 2026, potential approval in 20272028 Phase 2 results showed 24.2% weight loss at 48 weeks, the highest ever recorded for a GLP-1 class medication How to access now: Clinical trial enrollment (free), compounding pharmacies (with important legal caveats), or research peptides (grey market) When approved, retatrutide will be the first triple-agonist obesity medication (GLP-1 + GIP + glucagon) Is Retatrutide FDA Approved
Future studies can consider more flexible methods to handle possible non-linear relationships to improve understanding and accuracy